More than a century after Alzheimer’s disease was first described, research continues to shape what we know about the disease and what may be possible for the future. This #WorldAlzheimersDay, Carole Ho, Executive Vice President and President of Lilly Neuroscience reflects on how far we’ve come, and the work still ahead for people living with Alzheimer’s disease and those who care for them. Our commitment to advancing Alzheimer’s disease research continues. Learn more at our link in bio.